Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02819661
Other study ID # 0202-16-RMB CTIL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2018
Est. completion date June 30, 2019

Study information

Verified date May 2018
Source Rambam Health Care Campus
Contact Ronnie Klein
Phone +972-586972-195
Email ronnie@ir-medical.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will examine whether there is a difference in the frequencies of respiratory depression among obese women receiving spinal anesthesia combined with opioids compared to women with normal BMI.

If such a risk exists further investigation will be required to establish the proper criteria for the administration of morphine with spinal anesthesia to obese women.


Description:

Since 1979, intrathecal morphine combined with spinal anesthesia has been shown to provide effective postoperative analgesia in a variety of surgeries and more specifically in caesarean sections.

The advantages of addition of morphine to spinal analgesia are in prolonged analgesia during the operation and post operatively. In addition the analgesia is provided using a single injection during the time of surgery with no further need for complex and costly instruments like an opioid pump .

The side effects and risks of intrathecal morphine include: nausea, vomiting, pruritus urinary retention and the most severe being respiratory depression (immediate or delayed). The mild side effects were higher postoperatively in patients receiving spinal anesthesia combined with morphine. In a meta-analysis study of different surgeries performed under spinal anesthesia, it has been shown that at low doses (<0.3mg) intrathecal morphine does not increase the rate of respiratory depression. Nonetheless higher doses (>0.3mg) were associated with more incidents of respiratory depression. In another study there was no evidence of respiratory depression following caesarean section under spinal anesthesia combined with morphine. Yet, in a prospective study that reviewed 856 cases of caesarean sections under spinal anesthesia combined with morphine a rate of 8 incidences of respiratory depression were found. In a retrospective study of 1915 cases of women undergoing caesarean section with spinal anesthesia combined with morphine a rate of 0.25% of respiratory depression was reported.

The definition of respiratory depression is the lack of response to hypercapnia and/or hypoxia and it has been shown that intrathecal morphine depresses both responses. The common parameters that are monitored in order to detect respiratory depression include respiratory rate, sedation score, pulse oximetry, high PCo2 levels and the need for naloxone treatment. However, the overall measurement of frequency of respiratory depression postoperatively is variable. Accounting for this variability is the fact that hypercapnia may occur in patients with normal respiratory rate, normal sedation score and normal oxygen saturation. In addition, respiratory depression detected by high levels of PCo2 may be recognized earlier than with other parameters.

The risk factors that were found to be associated with respiratory depression included high BMI, prior opioid use, magnesium infusion and respiratory comorbidities In a study of 856 women 8 of them experienced oxygen desaturation during sleep. All of these women were extremely obese with a prior history of deep snoring.

In this study the investigators would like to examine whether there is a difference in the frequency of episodes of respiratory depression between obese (BMI≥30) and women with normal BMI receiving spinal anesthesia combined with intrathecal morphine during elective caesarean section. In previous studies it was reported that obese and non-obese women do not respond differently to modest doses of spinal anesthesia. Hence in this study the investigators can be certain that the investigators are examining the influence of addition of morphine to the spinal anesthesia.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Pregnancy

- Healthy women

Exclusion Criteria:

- Heart diseases

- Autoimmune diseases

- Respiratory diseases

Study Design


Intervention

Device:
SOMNOTOUCH RESP
Ventilatory effort recorder
Procedure:
Caesarean section
Cesarean delivery is defined as the delivery of a fetus through surgical incisions made through the abdominal wall (laparotomy) and the uterine wall (hysterotomy).
Drug:
Spinal anesthesia with intrathecal morphine
is a form of regional anaesthesia involving injection of a local anaesthetic into the subarachnoid space

Locations

Country Name City State
Israel Rambam healthcare campus Haifa Isreal

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evidence of clinical respiratory depression by SOMNOtouchTM device monitoring one year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03441282 - Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression
Completed NCT02907255 - Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery N/A
Completed NCT00544947 - Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section N/A
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Recruiting NCT05391555 - Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age Phase 2/Phase 3
Completed NCT02481570 - Anesthetic Optimization in Scoliosis Surgery N/A
Completed NCT06083272 - VitalThings Guardian Contactless Monitoring
Not yet recruiting NCT06064409 - Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study
Completed NCT00345384 - Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients Phase 1/Phase 2
Recruiting NCT04046068 - Multimodal Perioperative Pain Management: ComfortSafe Program
Active, not recruiting NCT04011163 - Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain Phase 2/Phase 3
Active, not recruiting NCT06374589 - Closed-Loop O2 Use During High Flow Oxygen Treatment Of Critical Care Adult Patients (CLOUDHFOT) N/A
Terminated NCT02760927 - Assessment of a Oral Endotracheal Tube Fastener on Patients Intubated With Oral Endotracheal Tubes N/A
Completed NCT01869582 - Safer Births - Reducing Perinatal Mortality N/A
Completed NCT00875134 - Testing of the Apnea Prevention Device Phase 1/Phase 2
Not yet recruiting NCT06137638 - ENA-001 for Post Operative Respiratory Depression (PORD) Phase 2
Completed NCT01843933 - Detecting Post-Operative Respiratory Depression in Children N/A
Completed NCT00696137 - Long-term Extension Study of BEMA™ Fentanyl Phase 3
Completed NCT04017702 - Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring
Withdrawn NCT04495452 - Precision Medicine in Anesthesia